Loading data
PRMENasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.63 m USD | 2.98 m USD | 0 USD | 0 USD | 0 USD |
| Research and development expense | 160.64 m USD | 155.29 m USD | 147.91 m USD | 86.73 m USD | 70.55 m USD |
| Operating profit | -208.35 m USD | -202.47 m USD | -204.79 m USD | -116.54 m USD | -84.47 m USD |
| Income tax expense | 0 USD | 0 USD | -279 k USD | -948 k USD | -486 k USD |
| Net income (reported basis) | -201.14 m USD | -195.88 m USD | -198.13 m USD | -121.82 m USD | -165.37 m USD |
| Net income attributable to common shareholders | -201.14 m USD | -195.88 m USD | -198.13 m USD | -142.01 m USD | -184.12 m USD |
| Basic earnings per share | -1.35 USD/share | -1.65 USD/share | -2.18 USD/share | -4.19 USD/share | -14.19 USD/share |
| Diluted earnings per share | -1.35 USD/share | -1.65 USD/share | -2.18 USD/share | -4.19 USD/share | -14.19 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.